Abstract
Purpose:Radiotherapy (RT) that selectively avoids irradiating highly functional lung regions may reduce pulmonary toxicity, which is substantial in lung cancer RT. Single-energy computed tomography (CT) pulmonary perfusion imaging has several advantages (e.g., higher resolution) over other modalities and has great potential for widespread clinical implementation, particularly in RT. The purpose of this study was to establish proof-of-principle for single-energy CT perfusion imaging.Methods:Single-energy CT perfusion imaging is based on the following: (1) acquisition of end-inspiratory breath-hold CT scans before and after intravenous injection of iodinated contrast agents, (2) deformable image registration (DIR) for spatial mapping of those two CT image data sets, and (3) subtraction of the precontrast image data set from the postcontrast image data set, yielding a map of regional Hounsfield unit (HU) enhancement, a surrogate for regional perfusion. In a protocol approved by the institutional animal care and use committee, the authors acquired CT scans in the prone position for a total of 14 anesthetized canines (seven canines with normal lungs and seven canines with diseased lungs). The elastix algorithm was used for DIR. The accuracy of DIR was evaluated based on the target registration error (TRE) of 50 anatomic pulmonary landmarks per subject for 10 randomly selected subjects as well as on singularities (i.e., regions where the displacement vector field is not bijective). Prior to perfusion computation, HUs of the precontrast end-inspiratory image were corrected for variation in the lung inflation level between the precontrast and postcontrast end-inspiratory CT scans, using a model built from two additional precontrast CT scans at end-expiration and midinspiration. The authors also assessed spatial heterogeneity and gravitationally directed gradients of regional perfusion for normal lung subjects and diseased lung subjects using a two-sample two-tailed t-test.Results:The mean TRE (and standard deviation) was 0.6 ± 0.7 mm (smaller than the voxel dimension) for DIR between pre contrast and postcontrast end-inspiratory CT image data sets. No singularities were observed in the displacement vector fields. The mean HU enhancement (and standard deviation) was 37.3 ± 10.5 HU for normal lung subjects and 30.7 ± 13.5 HU for diseased lung subjects. Spatial heterogeneity of regional perfusion was found to be higher for diseased lung subjects than for normal lung subjects, i.e., a mean coefficient of variation of 2.06 vs 1.59 (p = 0.07). The average gravitationally directed gradient was strong and significant (R2 = 0.99, p < 0.01) for normal lung dogs, whereas it was moderate and nonsignificant (R2 = 0.61, p = 0.12) for diseased lung dogs.Conclusions:This canine study demonstrated the accuracy of DIR with subvoxel TREs on average, higher spatial heterogeneity of regional perfusion for diseased lung subjects than for normal lung subjects, and a strong gravitationally directed gradient for normal lung subjects, providing proof-of-principle for single-energy CT pulmonary perfusion imaging. Further studies such as comparison with other perfusion imaging modalities will be necessary to validate the physiological significance.
Highlights
Pulmonary toxicity is substantial in lung cancer radiotherapy (RT), for locally advanced disease.[1,2]
Symptomatic radiation pneumonitis is a common toxicity that occurs in approximately 30% of patients irradiated for lung cancer, with fatal pneumonitis in about 2% of patients.[1,2]
RT that selectively avoids irradiating highly functional lung regions may reduce pulmonary toxicity. This hypothesis is supported by several reports in the literature, demonstrating that lung dose-function metrics improve predictive power for pulmonary toxicity compared to dose–volume metrics.[3–5]
Summary
Pulmonary toxicity is substantial in lung cancer radiotherapy (RT), for locally advanced disease.[1,2] Symptomatic (grade ≥ 2) radiation pneumonitis is a common toxicity that occurs in approximately 30% of patients irradiated for lung cancer, with fatal pneumonitis in about 2% of patients.[1,2] The current paradigm of RT is based on anatomic imaging and assumes a homogeneous radiation dose–response of normal tissues. Pulmonary toxicity is substantial in lung cancer radiotherapy (RT), for locally advanced disease.[1,2]. Symptomatic (grade ≥ 2) radiation pneumonitis is a common toxicity that occurs in approximately 30% of patients irradiated for lung cancer, with fatal pneumonitis in about 2% of patients.[1,2]. The current paradigm of RT is based on anatomic imaging and assumes a homogeneous radiation dose–response of normal tissues. RT that selectively avoids irradiating highly functional lung regions may reduce pulmonary toxicity. This hypothesis is supported by several reports in the literature, demonstrating that lung dose-function metrics improve predictive power for pulmonary toxicity compared to dose–volume metrics (the current clinical standard).[3–5]. Information of regional lung function, such as perfusion defect, was found to be beneficial in predicting toxicity.[6,7] This hypothesis is supported by several reports in the literature, demonstrating that lung dose-function metrics improve predictive power for pulmonary toxicity compared to dose–volume metrics (the current clinical standard).[3–5] In addition, information of regional lung function, such as perfusion defect, was found to be beneficial in predicting toxicity.[6,7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
